SCHEMBL3556218

SCHEMBL3556218

Cc1ccc(C(O)CC(Nc2ccc(Cl)cc2)c2ccccc2)cc1

nearest known ligand 0.56

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ MAPT P10636 6/20 0.56
▸ MEN1 O00255 4/20 0.56
▸ KMT2A Q03164 4/20 0.56
▸ TP53 P04637 4/20 0.56
▸ GAA P10253 4/20 0.56
▸ LMNA P02545 3/20 0.56
▸ SMN1; SMN2 Q16637 2/20 0.56
▸ NPSR1 Q6W5P4 2/20 0.56
▸ CYP3A4 P08684 2/20 0.56
▸ CYP2C9 P11712 2/20 0.56
▸ CYP2C19 P33261 2/20 0.56
▸ CYP1A2 P05177 1/20 0.56
▸ CYP2D6 P10635 1/20 0.56
▸ ATM Q13315 1/20 0.56
▸ XBP1 P17861 1/20 0.46
▸ NPBWR1 P48145 1/20 0.44
▸ MCHR1 Q99705 1/20 0.44
▸ THRB P10828 1/20 0.42
▸ SLC6A3 Q01959 2/20 0.42
▸ SLC6A2 P23975 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27671499 0.84 MAPT (0.44) MAPTMEN1KMT2ATP53GAA
SCHEMBL13315322 0.76 PGR (0.58) MAPTMEN1KMT2ATP53GAA
SCHEMBL29077356 0.75 MAPT (0.49) MAPTMEN1KMT2ATP53GAA
SCHEMBL431571 0.75 NPBWR1 (0.54) MAPTMEN1KMT2ATP53GAA
SCHEMBL27809584 0.73 HTR1A (0.40) MAPTMEN1KMT2ATP53GAA
SCHEMBL23409108 0.72 MEN1 (0.47) MAPTMEN1KMT2ATP53GAA
SCHEMBL29741303 0.71 TEAD4 (0.47) MAPTMEN1KMT2ATP53GAA
SCHEMBL8790210 0.71 MAPT (0.56) MAPTMEN1KMT2ATP53GAA
SCHEMBL29741345 0.71 MAPT (0.52) MAPTMEN1KMT2ATP53GAA
SCHEMBL14646364 0.71 FAAH (0.43) MEN1KMT2ASMN1; SMN2CYP3A4CYP1A2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20080293808-A1 Non-Steroidal Androgen Receptor Modulators, Preparation Process, Pharmaceutical Composition and Use Thereof SHANGHAI INSTITUTE OF MATERIA MEDICA CHINESE ACADEMY OF SCIENCES (CN) 2008-11-27 — — US claimed
EP-1889829-A1 NONSTEROIC ANDROGEN ACCEPTOR REGULATORS, PREPARATION PROCESS, PHARMACEUTICAL COMPOSITION AND USE THEREOF Shanghai Institute of Materia Medica, Chinese Academy of Sciences (CN) 2008-02-20 — — EP claimed
US-7737288-B2 Non-steroidal androgen receptor modulators, preparation process, pharmaceutical composition and use thereof SHANGHAI INSTITUTE OF MATERIA MEDICA CHINESE ACADEMY OF SCIENCES (CN) 2010-06-15 — — US disclosed
US-7737288-B2 Non-steroidal androgen receptor modulators, preparation process, pharmaceutical composition and use thereof SHANGHAI INSTITUTE OF MATERIA MEDICA CHINESE ACADEMY OF SCIENCES (CN) 2010-06-15 — — US disclosed
US-20080293808-A1 Non-Steroidal Androgen Receptor Modulators, Preparation Process, Pharmaceutical Composition and Use Thereof SHANGHAI INSTITUTE OF MATERIA MEDICA CHINESE ACADEMY OF SCIENCES (CN) 2008-11-27 — — US disclosed
US-20080293808-A1 Non-Steroidal Androgen Receptor Modulators, Preparation Process, Pharmaceutical Composition and Use Thereof SHANGHAI INSTITUTE OF MATERIA MEDICA CHINESE ACADEMY OF SCIENCES (CN) 2008-11-27 — — US disclosed
US-20080293808-A1 Non-Steroidal Androgen Receptor Modulators, Preparation Process, Pharmaceutical Composition and Use Thereof SHANGHAI INSTITUTE OF MATERIA MEDICA CHINESE ACADEMY OF SCIENCES (CN) 2008-11-27 — — US disclosed
EP-1889829-A1 NONSTEROIC ANDROGEN ACCEPTOR REGULATORS, PREPARATION PROCESS, PHARMACEUTICAL COMPOSITION AND USE THEREOF Shanghai Institute of Materia Medica, Chinese Academy of Sciences (CN) 2008-02-20 — — EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080293808-A1 Non-Steroidal Androgen Receptor Modulators, Preparation Process, Pharmaceutical Composition and Use Thereof AR, NR5A1, CYP17A1 MAPT 3155/4885MEN1 1215/4885KMT2A 4098/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback